Multi Indocitra Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Indocitra Tbk. trades at Rp530 (market cap 303B, 154.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multi Indocitra Tbk. is the larger of the two by market cap, and Multi Indocitra Tbk. is more actively traded (154.1K versus 96.7K). Which is the better fit depends on your goals.
| MICE | OBAT | |
|---|---|---|
Market Cap | 303B | 167.37B |
Volume | 154.1K | 96.7K |
Lot | 1.54K | 967 |
Turnover | 81.24M | 23.82M |
Average Price | 527.17 | 246.34 |
Value | 81.24M | 23.82M |
Indicative Equilibrium Price | — | 248 |
Indicative Equilibrium Volume | — | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →